Patent details
EP3377103
Title:
FUNCTIONAL ANTIBODY FRAGMENT COMPLEMENTATION FOR A TWO-COMPONENTS SYSTEM FOR REDIRECTED KILLING OF UNWANTED CELLS
Basic Information
- Publication number:
- EP3377103
- PCT Application Number:
- US2016062748
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP168672152
- PCT Publication Number:
- WO2017087789
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- FUNCTIONAL ANTIBODY FRAGMENT COMPLEMENTATION FOR A TWO-COMPONENTS SYSTEM FOR REDIRECTED KILLING OF UNWANTED CELLS
- French Title of Invention:
- COMPLÉMENTATION DE FRAGMENT D'ANTICORPS FONCTIONNEL POUR UN SYSTÈME À DEUX COMPOSANTS POUR LA DESTRUCTION REDIRIGÉE DE CELLULES INDÉSIRABLES
- German Title of Invention:
- KOMPLEMENTIERUNG EINES FUNKTIONELLEN ANTIKÖRPERFRAGMENTS FÜR EIN ZWEI-KOMPONENTEN-SYSTEM ZUR UMGELENKTEN TÖTUNG UNERWÜNSCHTER ZELLEN
- SPC Number:
-
Dates
- Filing date:
- 18/11/2016
- Grant date:
- 17/03/2021
- EP Publication Date:
- 26/09/2018
- PCT Publication Date:
- 26/05/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 17/03/2021
- EP B1 Publication Date:
- 17/03/2021
- EP B2 Publication Date:
- 12/03/2025
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 18/11/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/03/2025
-
-
- Name:
- Revitope Limited
- Address:
- Angel Building
407 St. John Street, London EC1V 4AD, United Kingdom (GB)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 12/04/2021
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- COBBOLD, Mark
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201562257552 P
- Priority Date:
- 19/11/2015
- Priority Country:
- United States (US)
2
- Priority Number:
- 201562270907 P
- Priority Date:
- 22/12/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 39/395;
A61K 45/06;
A61P 35/00;
C07K 14/47;
C07K 16/26;
C07K 16/18;
C07K 16/28;
C07K 16/30;
A61K 38/00;
A61K 39/00;
A61P 35/02;
A61P 37/04;
A61P 43/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202111
- Publication date:
- 17/03/2021
- Description:
- Grant (B1)
2
- Issue number:
- 202511
- Publication date:
- 12/03/2025
- Description:
- Patent maintained (B2 publication)
Annual Fees
- Annual Fee Due Date:
- 01/12/2025
- Annual Fee Number:
- 10
- Annual Fee Amount:
- 131 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 26/11/2024
- Last Annual Fee Paid Number:
- 9
- Last Annual Fee Paid Amount:
- 115 Euro
- Payer:
- DENNEMEYER & CO